EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance

Abstract excerpt

The epidermal growth factor receptor (EGFR) has served as the founding member of the large family of growth factor receptors harboring intrinsic tyrosine kinase function. High abundance of EGFR and large internal deletions are frequently observed in brain tumors, whereas point mutations and small insertions within the kinase domain are common in lung cancer. For these reasons EGFR and its preferred heterodimer...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer-related molecular mechanisms research
• Share to Colorectal Cancer Treatments and Studies
• Share to Lung Cancer Treatments and Mutations